THE LEVELS OF CA 19-9, CEA, AND CA 72-4 IN EROSIVE GASTRITIS

被引:0
作者
Yildiz, Ramazan [1 ]
Cindoruk, Mehmet [2 ]
Buyukberber, Suleyman [1 ]
Kaya, Ali Osman [1 ]
Yaman, Emel [1 ]
Ozturk, Banu [1 ]
Coskun, Ugur [1 ]
Benekli, Mustafa [1 ]
机构
[1] Gazi Univ, Tip Fak, Tibbi Onkol Bilim Dali, Ankara, Turkey
[2] Gazi Univ, Tip Fak, Gastroenterol Bilim Dali, Ankara, Turkey
来源
GAZI MEDICAL JOURNAL | 2009年 / 20卷 / 02期
关键词
Erosive Gastritis; Tumor Marker; CEA; CA; 19-9; 72-4;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To investigate the clinical significance of serum CEA, CA 19-9, and CA 72-4 levels in patients with erosive gastritis in whom malignancy was ruled out. Materials and Methods: Forty patients (12 males, 28 females) diagnosed with erosive gastritis by esophagogastroduodenoscopy and having measured tumor marker levels were assessed. Results: Increased CA 19-9 level was reported in 4 patients (patient 1: 593.3 U/ml; patient 2: 75.8 U/ml; patient 3: 49.9 U/ml; patient 4: 44.8 U/ml). CEA and CA 72-4 levels increased in one patient, 6.33 ng/ml and 5.42 U/ml, respectively. The mean of these markers for the other patients were as follows: CA 19-9: 8.12 +/- 8.18 U/ml, CEA: 1.67 +/- 0.93 ng/ml, and CA 72-4: 1.64 +/- 1.05 U/ml. Conclusion: Although it was not diagnostic, erosive gastritis may be another cause of tumor marker elevation.
引用
收藏
页码:59 / 60
页数:2
相关论文
共 11 条
[1]   The prognostic significance of gastric juice CA 19-9 and CEA levels in gastric carcinoma patients [J].
Duraker, N ;
Çelik, AN ;
Gençler, N .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2002, 28 (08) :844-849
[2]   CA-19-9 DETERMINATION IN GASTRIC-JUICE - ROLE IN IDENTIFYING GASTRIC-CANCER AND HIGH-RISK PATIENTS [J].
FARINATI, F ;
NITTI, D ;
CARDIN, F ;
DIMARIO, F ;
COSTA, F ;
ROSSI, C ;
MARCHETT, A ;
LISE, M ;
NACCARATO, R .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (05) :923-927
[3]  
Grem Jean, 1997, Current Opinion in Oncology, V9, P380, DOI 10.1097/00001622-199709040-00012
[4]  
HARRISON JD, 1989, EUR J SURG ONCOL, V15, P253
[5]  
Kirkwood K S, 1997, Surg Oncol Clin N Am, V6, P495
[6]   IMMUNOREACTIVE CARCINOEMBRYONIC ANTIGEN IN GASTRIC-JUICE IN PATIENTS WITH GASTRIC-CANCER [J].
KOJIMA, O ;
TANIOKU, T ;
KITAGAWA, N ;
OH, A ;
UEHARA, Y ;
KURIMOTO, T ;
MAJIMA, T ;
IKEDA, E ;
NISHIOKA, B ;
FUJITA, Y ;
MAJIMA, S .
JAPANESE JOURNAL OF SURGERY, 1983, 13 (04) :324-330
[7]   USEFULNESS OF CARCINOEMBRYONIC ANTIGEN MEASUREMENT IN GASTRIC-JUICE OF PATIENTS WITH GASTRIC DISORDERS [J].
MICALI, B ;
FLORIO, MG ;
VENUTI, A ;
ARTEMISIA, A ;
CAPUTO, G ;
BRANCATO, U .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1983, 5 (05) :411-415
[8]   An endogastric capsule for measuring tumor markers in gastric juice: an evaluation of the safety and efficacy of a new diagnostic tool [J].
Muretto, P ;
Graziano, F ;
Staccioli, MP ;
Barbanti, I ;
Bartolucci, A ;
Paolini, G ;
Giordano, D ;
Testa, E ;
De Gaetano, A .
ANNALS OF ONCOLOGY, 2003, 14 (01) :105-109
[9]  
PIANTINO P, 1990, International Journal of Biological Markers, V5, P77
[10]   CARCINOEMBRYONIC ANTIGEN-LIKE ACTIVITY IN GASTRIC-JUICE AND PLASMA IN PATIENTS WITH GASTRIC DISORDERS [J].
SATAKE, K ;
YAMASHITA, K ;
KITAMURA, T ;
TEI, Y ;
UMEYAMA, K .
AMERICAN JOURNAL OF SURGERY, 1980, 139 (05) :714-718